Table of Contents Table of Contents
Previous Page  369 / 435 Next Page
Information
Show Menu
Previous Page 369 / 435 Next Page
Page Background

Multi Laboratory Test – AOAC First Action Method 2012.22 Ascorbic Acid (Vitamin C) in Infant Formula and

Adult/Pediatric Nutritionals.

RDLS-RD150006

E. Campos Giménez (NRC, Lausanne)

Page 7

CONFIDENTIAL

The contents of this document constitute a trade secret and the intellectual property rights thereto belong to Nestlé S. A., Vevey, Switzerland.

This document may not be reproduced or disclosed to third parties without prior authorisation.

INSTRUCTIONS TO PARTICIPANTS

Part 1: Method set up and qualification of participants

Practice

Samples

Receipt

All participant laboratories received two practice samples. The “SPIFAN Practice

Samples Receipt Form” (see Annex E) was to be filled and sent back to the

Study Director.

Before undertaking the analysis, were instructed to keep the samples at room

temperature, away from direct sunlight. Once open, the containers were to be

kept at 4 °C in tightly closed containers for the duration of the study.

Analysis

The laboratories set up the method described in Annex B. It was highlighted

to closely follow the method described in this document, since small

adaptations might have been included with respect to the previously

published method.

The laboratories were asked to analyze each of the two practice samples in

duplicate (two extractions from each reconstituted sample). Any deviation,

such as necessity to substitute reagents, columns, apparatus or instruments,

was to be recorded and reported.

Timeline

The results on the two practice samples were to be sent to the Study Director

within 6 weeks from sample reception.

Reporting

An electronic template was provided for data reporting (see Annex F).

Participating laboratories were required to report peak areas in the standard

curve, as well as in the sample extracts. Furthermore, detailed information on

the different masses and volumes used during sample preparation as

indicated in the method, as well as raw data (chromatograms of standards

and samples) were requested.

Laboratories were asked to report final results in mg ascorbic acid/100 g of

“reconstituted powder” for powder samples or “as is” for liquid products, with

3 significant figures.

Laboratory

Qualification

After review by the Study Director, results within a range of expected levels

identified the laboratories which had the capability to run the analysis

successfully. They were thus qualified for the second part of the study. The

laboratories received notification within 2 weeks from data reporting.

AOAC OMB Meeting Book

341